The Recall Desk
SevereFDA (Devices)·Z-2387-2023·Announced 2023-08-23

Dialysis Catheters Recalled by FDA for Tip Obstruction Risk

Covidien is recalling MAHURKAR acute dialysis catheters because the center lumen tip may be occluded by excessive silicone-based lubricant. Obstruction could delay treatment or cause embolism and thrombosis.

What this means for you

Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: This is an FDA Class I medical device recall involving a manufacturing defect that can cause serious patient harm, including catheter obstruction, hemolysis, embolism, and thrombosis. The Class I classification mandates a minimum score of 4 per the rubric, despite no reported illnesses or deaths in the source text.

Plain-English summary

Covidien LP is recalling MAHURKAR 12 Fr High Pressure Triple Lumen Acute Dialysis Catheters (REF: 8888345611HP). The recall involves 32,125 units distributed nationwide and internationally.

The center lumen of the catheter tip may contain an occlusion caused by excessive or uncured silicone-based lubricant (MDX). This defect can lead to complete or partial obstruction of blood flow through the catheter, or to dislodgement of lubricant particles into the bloodstream.

Healthcare providers should immediately discontinue use of affected catheters and check lot numbers against the recall list. Facilities must identify and segregate affected units to prevent patient use.

Potential complications from affected catheters include delayed dialysis treatment, hemolysis, embolism, and thrombosis.

The recalled product

Product
MAHURKAR 12 Fr High Pressure Triple Lumen Acute Dialysis Catheter, 16 cm, Curved Extensions, Kit REF: 8888345611HP
Manufacturer
Covidien LP
Hazard
  • catheter-obstruction
  • hemolysis
  • embolism
  • thrombosis

Distribution

Distributed nationwide across the United States.